Report Title:

Chelation Therapy (SD1)

RESOLUTION

WHEREAS, chelation therapy, which involves the intravenous administration of a synthetic amino acid, has been used successfully for over forty years to treat vascular disease; and

WHEREAS, in the chelation process, the synthetic amino acid binds with heavy metals and removes them from the blood system, thereby reducing free radical damage to the blood vessels and other tissues, and improving circulation throughout the body; and

WHEREAS, it is believed that chelation therapy can also reduce the risk of developing many chronic degenerative diseases, such as cancer, inflammatory joint disease, asthma, diabetes, senile dementia, and degenerative eye disease; and

WHEREAS, the American College for Advancement in Medicine has published a modern protocol for the safe and effective administration of chelation therapy; and

WHEREAS, while no deaths or serious complications have been reported in patients treated with this protocol, as with any type of treatment, proper administration is necessary; and

WHEREAS, it is critical that physicians have the proper education and training in chelation therapy; now, therefore,

BE IT RESOLVED by the Senate of the Twenty-First Legislature of the State of Hawaii, Regular Session of 2001, the House of Representatives concurring, that the University of Hawaii, John A. Burns School of Medicine is requested to urge its students to study chelation therapy; and

BE IT FURTHER RESOLVED that a certified copy of this Concurrent Resolution be transmitted to the University of Hawaii John A. Burns School of Medicine.